← Back to Search

Treatment for Brain Aneurysm (CAFI Trial)

N/A
Waitlist Available
Led By Thomas Liebig, MD
Research Sponsored by Cerus Endovascular, Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who are suitable for non-emergency endovascular embolization of saccular IAs
IA located at a bifurcation in the anterior or posterior circulation with dimensions consistent with implant size selection guidelines included in the IFU
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

CAFI Trial Summary

This trial will enroll up to 150 patients at up to 30 sites in the United States.

Eligible Conditions
  • Brain Aneurysm

CAFI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are eligible for a non-emergency procedure called endovascular embolization to treat a specific type of brain aneurysm called saccular IAs.
Select...
You have an aneurysm located at a specific point in your blood vessels that is too large to be treated with the available device.

CAFI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The occlusion rate as adjudicated by a core laboratory.
The proportion of subjects with death of any non-accidental cause or any major disabling stroke after treatment or major disabling stroke or death due to neurological cause.

Find a Location

Who is running the clinical trial?

Cerus Endovascular, LtdLead Sponsor
5 Previous Clinical Trials
277 Total Patients Enrolled
Thomas Liebig, MDPrincipal InvestigatorKlinikum der Universität München
1 Previous Clinical Trials
34 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT04187573 — N/A
Brain Aneurysm Research Study Groups:
Brain Aneurysm Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT04187573 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04187573 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available openings for participation in this experiment?

"According to the clinicaltrials.gov database, this protocol has not been actively recruiting since January 25th 2022 and is no longer seeking participants. Nonetheless, there are 153 other medical trials presently in need of volunteers."

Answered by AI

Are there any specific criteria for joining this experiment?

"This trial is searching for 38 participants that are diagnosed with berry aneurysm between the ages of 18-80. To be considered, applicants must have adequate cognitive faculties to agree and abide by the study parameters, in addition to being ideal candidates for non-emergency endovascular embolization."

Answered by AI

Can those over the age of sixty partake in this research?

"Qualified enrollees must be between 18 and 80 years of age. Those under the legal age for consent can participate in 7 trials, while individuals older than 65 may enter 151 separate studies."

Answered by AI
~7 spots leftby Mar 2025